Overview

Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
14-week single blind, double baseline, forced-titration, cross-over comparison of the cardiac benefits of Coreg CR compared to valsartan added to existing ACE inhibition
Phase:
Phase 3
Details
Lead Sponsor:
State University of New York at Buffalo
Collaborator:
GlaxoSmithKline
Treatments:
Carvedilol
Lisinopril
Valsartan